Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Biosight Ltd. logo — Developing innovative pharmaceuticals for hematological mali...

Biosight Ltd.

Developing innovative pharmaceuticals for hematological malignancies and disorders

Founded 2000 Israel Israel 3 employees Series C Total: $59.00M Biotechnology, Health Care +2

General Information

Company Name Biosight Ltd.
Founded Year 2000
Location Israel Israel +1
Employees 3
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series C
Social

Get notified when Biosight Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Biosight Ltd.

Biosight Ltd. is a biotech company founded in 2000, headquartered in Israel, and is currently in the Phase 2 clinical stage of development. The company is focused on developing innovative pharmaceuticals for hematological malignancies and disorders, with its lead product, BST-236 (aspacytarabine), showing promising results. The drug addresses unmet medical needs by enabling high-dose chemotherapy with reduced systemic toxicity. Recently, Biosight secured a $27.00M Series C investment on 02 December 2020 from a group of investors including Primera Capital, Israel Biotech Fund, Migdal Insurance and Financial Holdings, Arkin Bio Ventures, Phoenix Insurance Company, and Biotel. The company's progression to Phase 2b for the first-line treatment of acute myeloid leukemia (AML), as well as the upcoming Phase 2 study for relapsed/refractory AML and myelodysplastic syndrome (MDS) in collaboration with GFM, demonstrates the substantial potential of Biosight's offerings in addressing critical medical challenges. The alliance with the European cooperative group further validates Biosight's commitment to advancing therapeutic solutions and could potentially open doors to a broader market.

Taxonomy: Pharmaceutical development, Biotech, Acute myeloid leukemia, Myelodysplastic syndrome, Hematological malignancies, Chemotherapy, Clinical stage biotech, Phase 2 clinical, Innovative therapeutics, Targeted chemotherapy, Pro-drugs, AML treatment, MDS treatment

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 6
Investor Investor
•••• •••• 		02 Dec 2020
Series C •••••• 3
Investor
•••• •••• 		11 Mar 2020
Venture Round •••••• 1
Investor
16 May 2016
Venture Round •••••• - 01 Jan 2007

Biosight Ltd. Alternatives & Competitors

Biosight Ltd. vs
Combat Medical Ltd
Combat Medical Ltd United Kingdom

Transforming Cancer Treatments Through World Leading Hyperthermic Technologies

26 employees
Biosight Ltd. vs
DNAtrix
DNAtrix United States

DNAtrix is a privately held biotech company developing virus-driven immunotherapies to treat cancer....

Series Unknown
3 employees
Biotechnology, Health Care
Biosight Ltd. vs
The START Center for Cancer Care
The START Center for Cancer Care United States

Global leader in cancer treatment and oncology research. The Cure Starts Here!

270 employees
Health Care

FAQ About Biosight Ltd.

Developing innovative pharmaceuticals for hematological malignancies and disorders
Biosight Ltd. was founded in 2000.
Biosight Ltd. is headquartered in Israel.
Biosight Ltd. operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.
Biosight Ltd. has approximately 3 employees.
Biosight Ltd. has completed 4 funding rounds, raising a total of $59.00M. The latest funding stage is Series C.
Top alternatives and competitors to Biosight Ltd. include Combat Medical Ltd, DNAtrix, The START Center for Cancer Care, Ascelia Pharma AB, BeyondSpring. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biosight Ltd. and Combat Medical Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Biosight Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy